C-Terminal Fragment, Aβ39–42-Based Tetrapeptides Mitigates Amyloid-β Aggregation-Induced Toxicity
Author:
Affiliation:
1. Department of Microbial Biotechnology, Punjab University, Sector 14, Chandigarh 160 014, India
2. International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110 067, India
Funder
Council of Scientific and Industrial Research
Publisher
American Chemical Society (ACS)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.acs.org/doi/pdf/10.1021/acsomega.8b01522
Reference44 articles.
1. An english translation of alzheimer's 1907 paper, ?�ber eine eigenartige erkankung der hirnrinde?
2. Improving Healthcare for People Living with Dementia: Coverage, Quality and Costs Now and in the Future. Alzheimer’s Disease International, World Alzheimer Report, https://www.alz.co.uk/research/world-report-2016, 2016 (accessed June 20, 2018).
3. A Phase 3 Trial of Semagacestat for Treatment of Alzheimer's Disease
4. O1‐04‐07: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18‐month international multi‐center phase 3 trial
5. Subacute meningoencephalitis in a subset of patients with AD after A 42 immunization
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis and mechanistic study of Aβ42 C-terminus domain derived tetrapeptides that inhibit Alzheimer’s Aβ-aggregation-induced neurotoxicity;Bioorganic & Medicinal Chemistry Letters;2024-11
2. Synthesis and mechanistic study of ultrashort peptides that inhibits Alzheimer’s Aβ-aggregation-induced neurotoxicity;Bioorganic Chemistry;2024-03
3. Current strategies of detecting Aβ species and inhibiting Aβ aggregation: Status and prospects;Coordination Chemistry Reviews;2023-11
4. Stimuli-Responsive Membrane Anchor Peptide Nanofoils for Tunable Membrane Association and Lipid Bilayer Fusion;ACS Applied Materials & Interfaces;2022-12-06
5. Breaker peptides against amyloid-β aggregation: a potential therapeutic strategy for Alzheimer’s disease;Future Medicinal Chemistry;2021-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3